208 related articles for article (PubMed ID: 18088393)
1. Continuous glucose monitoring in patients with insulinoma.
Munir A; Choudhary P; Harrison B; Heller S; Newell-Price J
Clin Endocrinol (Oxf); 2008 Jun; 68(6):912-8. PubMed ID: 18088393
[TBL] [Abstract][Full Text] [Related]
2. Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism.
Vezzosi D; Bennet A; Courbon F; Caron P
Clin Endocrinol (Oxf); 2008 Jun; 68(6):904-11. PubMed ID: 18031316
[TBL] [Abstract][Full Text] [Related]
3. Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks.
Christesen HB; Brusgaard K; Beck Nielsen H; Brock Jacobsen B
Clin Endocrinol (Oxf); 2008 May; 68(5):747-55. PubMed ID: 18208578
[TBL] [Abstract][Full Text] [Related]
4. Glycaemic profile characteristics and frequency of impaired awareness of hypoglycaemia in subjects with T1D and repeated hypoglycaemic events.
Giménez M; Lara M; Jiménez A; Conget I
Acta Diabetol; 2009 Dec; 46(4):291-3. PubMed ID: 19107319
[TBL] [Abstract][Full Text] [Related]
5. [Anesthetic management of pediatric patients with insulinoma using continuous glucose monitoring].
Manabe M; Morimatsu H; Egi M; Suzuki S; Kaku R; Matsumi M; Morita K
Masui; 2009 Jun; 58(6):757-9. PubMed ID: 19522271
[TBL] [Abstract][Full Text] [Related]
6. Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma.
Healy ML; Dawson SJ; Murray RM; Zalcberg J; Jefford M
Intern Med J; 2007 Jun; 37(6):406-9. PubMed ID: 17535385
[TBL] [Abstract][Full Text] [Related]
7. Risk for severe hypoglycaemia with unawareness in GH-deficient patients during the insulin tolerance test.
Holmer H; Link K; Erfurth EM
Clin Endocrinol (Oxf); 2006 Feb; 64(2):136-40. PubMed ID: 16430710
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of insulinoma with diazoxide].
Mateu MV; González Pardo FO; Cristino A; Lasdica S; Fainstein D
Medicina (B Aires); 2003; 63(1):51-3. PubMed ID: 12673963
[TBL] [Abstract][Full Text] [Related]
9. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
[TBL] [Abstract][Full Text] [Related]
10. Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.
Lheureux PE; Zahir S; Penaloza A; Gris M
Crit Care; 2005; 9(6):543-9. PubMed ID: 16356235
[TBL] [Abstract][Full Text] [Related]
11. Insulinoma: how reliable is the biochemical evidence?
Chammas NK; Teale JD; Quin JD
Ann Clin Biochem; 2003 Nov; 40(Pt 6):689-93. PubMed ID: 14629810
[TBL] [Abstract][Full Text] [Related]
12. Insulinoma in a third-trimester pregnant woman combined with pre-eclampsia: a case report and review of the diagnostic strategies.
Christiansen E; Vestergaard H
Gynecol Endocrinol; 2008 Jul; 24(7):417-22. PubMed ID: 18645715
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of endocrine tests. D: the prolonged fasting test for insulinoma.
van Bon AC; Benhadi N; Endert E; Fliers E; Wiersinga WM
Neth J Med; 2009; 67(7):274-8. PubMed ID: 19687521
[TBL] [Abstract][Full Text] [Related]
14. Reversal of pentamidine-induced hypoglycaemia with oral diazoxide.
Fitzgerald DB; Young IS
J Trop Med Hyg; 1984 Feb; 87(1):15-9. PubMed ID: 6371261
[TBL] [Abstract][Full Text] [Related]
15. [Differences in insulin secretion facilitate the differential diagnosis of insulinoma and factitious hypoglycaemia].
Meier JJ; Hücking K; Grüneklee D; Schmiegel W; Nauck MA
Dtsch Med Wochenschr; 2002 Feb; 127(8):375-8. PubMed ID: 11859446
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostics and treatment of organic hyperinsulinism--experience in 105 cases].
Skrha J; Sváb J; Krusina L; Dusková J; Hilgertová J; Keil R
Cas Lek Cesk; 2009; 148(8):389-94. PubMed ID: 19899726
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Treatment Course of Insulinoma Presenting as Hypoglycemia Unawareness Using a Factory-Calibrated Continuous Glucose Monitoring System.
Aida A; Noto H
Am J Case Rep; 2022 Jul; 23():e936723. PubMed ID: 35908172
[TBL] [Abstract][Full Text] [Related]
18. Application of the intravenous glucose tolerance test and the minimal model to patients with insulinoma: insulin sensitivity (Si) and glucose effectiveness (Sg) before and after surgical excision.
Vethakkan SR; Walters JM; Gooley JL; Boston RC; Ward GM
Clin Endocrinol (Oxf); 2009 Jan; 70(1):47-52. PubMed ID: 18445139
[TBL] [Abstract][Full Text] [Related]
19. Hypoglycaemia unawareness.
Vignesh JP; Mohan V
J Assoc Physicians India; 2004 Sep; 52():727-32. PubMed ID: 15839452
[TBL] [Abstract][Full Text] [Related]
20. A mysterious case of normalising blood sugar: insulinoma in a long-standing diabetic patient.
Hameed MF; Hoyle GE; Muir Z
Age Ageing; 2006 May; 35(3):317-8. PubMed ID: 16638774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
